Evidence map›Paper›PMID 27885552›Full record

ArticleAIDS and behavior2017

PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.

Andrew E Petroll, Jennifer L Walsh, Jill L Owczarzak, Timothy L McAuliffe, Laura M Bogart, Jeffrey A Kelly

Abstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew E PetrollCenter for AIDS Intervention Research (CAIR), Medical College of Wisconsin, 2071 N. Summit Avenue, Milwaukee, WI, 53202, USA. apetroll@mcw.edu.
Jennifer L WalshCenter for AIDS Intervention Research (CAIR), Medical College of Wisconsin, 2071 N. Summit Avenue, Milwaukee, WI, 53202, USA.
Jill L OwczarzakJohns Hopkins University, Baltimore, MD, USA.
Timothy L McAuliffeCenter for AIDS Intervention Research (CAIR), Medical College of Wisconsin, 2071 N. Summit Avenue, Milwaukee, WI, 53202, USA.
Laura M BogartRAND Corporation, Santa Monica, CA, USA.
Jeffrey A KellyCenter for AIDS Intervention Research (CAIR), Medical College of Wisconsin, 2071 N. Summit Avenue, Milwaukee, WI, 53202, USA.

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
QUANTITATIVE COREP30MH052776 · NIMH · MEDICAL COLLEGE OF WISCONSIN · PI KELLY, JEFFREY A · 1994 to 2018
$33.2M
Integrative Data Analysis of HIV Prevention TrialsK01MH099956 · NIMH · MIRIAM HOSPITAL · PI WALSH, JENNIFER LYNN · 2013 to 2017
$793k
NIMH NIH HHS K01 MH099956NIMH NIH HHS P30 MH052776NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

HIV pre-exposure prophylaxis (PrEP) was FDA approved in 2012, but uptake remains low. To characterize what would facilitate health care providers' increased PrEP prescribing, we conducted a 10-city, online survey of 525 primary care providers (PCPs) and HIV providers (HIVPs) to assess awareness, knowledge, and experience with prescribing PrEP; and, comfort with and barriers to PrEP-related activities. Fewer PCPs than HIVPs had heard of PrEP (76 vs 98%), felt familiar with prescribing PrEP (28 vs. 76%), or had prescribed it (17 vs. 64%). PCPs were less comfortable than HIVPs with PrEP-related activities such as discussing sexual activities (75 vs. 94%), testing for acute HIV (83 vs. 98%), or delivering a new HIV diagnosis (80 vs. 95%). PCPs most frequently identified limited knowledge about PrEP and concerns about insurance coverage as prescribing barriers. PCPs and HIVPs differ in needs that will facilitate their PrEP prescribing. Efforts to increase PrEP uptake will require interventions to increase the knowledge, comfort, and skills of providers to prescribe PrEP.

Indexed as

Attitude of Health PersonnelAwarenessPhysicians, Primary CarePre-Exposure ProphylaxisRecognition, PsychologyAdultAnti-HIV AgentsFemaleHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaleMiddle AgedStereotypingSurveys and QuestionnairesAnti-HIV AgentsBarriersHealth care providersHIV pre-exposure prophylaxisHIV prevention

Identifiers

PMID27885552
PMCPMC5500978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.